Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
NOK 0.41
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Strong growth
Data is available to registered users only
Data is available to registered users only
About
Lifecare AS engages in the research and development of medical sensors for health monitoring in Norway. It develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes. The company was founded in 2006 and is headquartered in Bergen, Norway.
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers.
Data is available to registered users only
Target Price
The average target price of LIFE.OL is 0.65 and suggests 8% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendatio
Data is available to registered users only
Buy
Sell